Role of glucagon and adrenergic receptors in thyrocalcitonin release in the dog.
D000227:Adenine Nucleotides / Q000378:metabolism*; D000262:Adenylyl Cyclases / Q000378:metabolism; D000818:Animals; D002116:Calcitonin / Q000378:metabolism*; D000242:Cyclic AMP / Q000378:metabolism; D004285:Dogs; D004837:Epinephrine / Q000494:pharmacology*; D005260:Female; D005934:Glucagon / Q000494:pharmacology*; D006996:Hypocalcemia / Q000139:chemically induced; D007545:Isoproterenol / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D011984:Sensory Receptor Cells / Q000187:drug effects; D013268:Stimulation, Chemical; D013564:Sympathetic Nervous System / Q000187:drug effects; D013806:Theophylline / Q000494:pharmacology
D000227:Adenine Nucleotides; D002116:Calcitonin; D005934:Glucagon; D011433:Propranolol; D013806:Theophylline; D000242:Cyclic AMP; D000262:Adenylyl Cyclases; D007545:Isoproterenol; D004837:Epinephrine; D010646:Phentolamine